Compare CTRA & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTRA | ZBH |
|---|---|---|
| Founded | 1989 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.1B | 18.7B |
| IPO Year | 1990 | N/A |
| Metric | CTRA | ZBH |
|---|---|---|
| Price | $25.43 | $89.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 20 |
| Target Price | $32.81 | ★ $107.00 |
| AVG Volume (30 Days) | ★ 6.5M | 2.2M |
| Earning Date | 11-03-2025 | 02-05-2026 |
| Dividend Yield | ★ 3.46% | 1.06% |
| EPS Growth | ★ 31.20 | N/A |
| EPS | 2.17 | ★ 4.03 |
| Revenue | $6,666,000,000.00 | ★ $8,010,900,000.00 |
| Revenue This Year | $47.52 | $7.99 |
| Revenue Next Year | $5.65 | $5.20 |
| P/E Ratio | ★ $11.74 | $22.41 |
| Revenue Growth | ★ 25.92 | 5.47 |
| 52 Week Low | $22.33 | $85.33 |
| 52 Week High | $29.95 | $114.44 |
| Indicator | CTRA | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 44.14 | 37.86 |
| Support Level | $25.28 | $90.46 |
| Resistance Level | $27.11 | $92.82 |
| Average True Range (ATR) | 0.56 | 2.09 |
| MACD | -0.24 | -0.24 |
| Stochastic Oscillator | 9.82 | 10.05 |
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.